Skip to main content
logo
Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
78.90
+2.70 (3.54%)
Sep 18, 2026, 1:30 PM CST

Lumosa Therapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
13,21532,76642,22411,2686,4256,117
Market Cap Growth
-75.33%-22.40%274.74%75.37%5.04%17.77%
Enterprise Value
12,59231,94541,69910,3805,2544,757
Last Close Price
78.90194.50250.0068.1539.3140.16

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----63.75
PS Ratio
384.52914.461078.41197.97241.17352.32
PB Ratio
10.6121.5721.917.893.852.89
P/TBV Ratio
10.6821.7122.098.054.012.95

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-891.551065.00182.37197.19273.96

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.000.010.000.01
Net Debt / Equity Ratio
-0.51-0.52-0.70-0.58-0.71-0.68
Net Debt / EBITDA Ratio
2.102.403.812.334.093.57
Net Debt / FCF Ratio
2.412.194.532.433.903.18
Asset Turnover
0.020.020.020.030.010.01
Inventory Turnover
0.160.140.210.140.130.13
Quick Ratio
5.266.286.923.985.656.60
Current Ratio
6.477.377.644.766.447.23
Return on Equity (ROE)
-26.11%-20.11%-26.03%-16.16%-26.63%5.18%
Return on Assets (ROA)
-12.15%-11.02%-11.78%-13.26%-9.03%-13.01%
Return on Capital Employed (ROCE)
-24.40%-22.00%-18.50%-26.20%-18.30%-20.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.80%-1.04%-1.01%-2.11%-7.70%1.57%
FCF Yield
-1.98%-1.10%-0.70%-3.04%-4.71%-7.40%
Buyback Yield / Dilution
-0.40%-1.68%-0.64%-0.03%-7.61%-24.92%